Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

BI Nutraceuticals Extends Ingredient Sourcing Reach To Build Customer Base

This article was originally published in The Tan Sheet

Executive Summary

With a manufacturing plant in China, an expanding portfolio of ingredients and significant investments in quality control, BI Nutraceuticals believes it is positioned to grow in a post-GMP world

You may also be interested in...



Carlyle Group's $3.8B Bid For NBTY Could Face Competition

The Carlyle Group's planned acquisition of NBTY for $3.8 billion may not be the only private equity offer to surface for the dietary supplement giant

Herbalife's Frankos Sees GMP Challenges In New Light After Leaving FDA

Vasilios "Bill" Frankos, former director of FDA's Division of Dietary Supplement Programs, left his mark on the industry after shepherding the supplement good manufacturing practices final rule from development to publication and through implementation

As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle

FDA's final rule for dietary supplement good manufacturing practices completed its phase-in for the industry June 25, and the agency now prepares to conduct inspections of small firms, which have struggled the most to comply with the regulation

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS104325

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel